Karl-Erik Andersson to Cancer Vaccines
This is a "connection" page, showing publications Karl-Erik Andersson has written about Cancer Vaccines.
Connection Strength
0.210
-
Hillerdal V, Boura VF, Björkelund H, Andersson K, Essand M. Avidity characterization of genetically engineered T-cells with novel and established approaches. BMC Immunol. 2016 07 13; 17(1):23.
Score: 0.122
-
Huijbers EJ, Femel J, Andersson K, Björkelund H, Hellman L, Olsson AK. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development. Vaccine. 2012 Jan 05; 30(2):225-30.
Score: 0.088